Vitamin K2 Market - Global Forecast to 2029
| 出版年月 | 2024年6月 |
| ページ数 | 228 |
| 図表数 | 281 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
Report Overview
The global vitamin K2 market is estimated to be valued at USD 140 million in 2024 and is projected to reach USD 265 million by 2029 at a CAGR of 13.7%.
世界のビタミンK2 市場は、2024 年に 1 億 4,000 万米ドルと推定され、CAGR 13.7% で 2029 年までに 2 億 6,500 万米ドルに達すると予測されています。
The growth of the Vitamin K2 market is propelled by advancements in research and development. Ongoing studies continue to uncover new health benefits and potential applications for Vitamin K2, thereby expanding its appeal. These emerging benefits contribute to a broader consumer base and create new opportunities for product innovation in the nutraceutical and functional food sectors.
Furthermore, market growth is facilitated by increasing consumer awareness and education. Campaigns and informational resources provided by health organizations and supplement manufacturers have significantly raised awareness about the importance of Vitamin K2. This has led to higher consumer confidence and an uptick in the consumption of Vitamin K2-enriched products. Additionally, the trend towards personalized nutrition, where consumers seek tailored dietary solutions to meet their specific health needs, has spurred demand for Vitamin K2 supplements.
“During the forecast period, the health supplements segment in applications emerges as the dominant segment in the vitamin K2 market.”
This trend is largely driven by the increasing consumer inclination towards preventive healthcare and wellness. As individuals become more aware of the long-term benefits of maintaining bone and cardiovascular health, the demand for effective and reliable supplements has surged. Vitamin K2, known for its crucial role in calcium metabolism and cardiovascular protection, is gaining significant traction among health-conscious consumers.
One of the primary reasons for the dominance of the health supplements segment is the growing body of scientific evidence supporting the efficacy of Vitamin K2. Numerous studies have highlighted its role in promoting bone density and preventing arterial calcification, thereby reducing the risk of osteoporosis and cardiovascular diseases. These benefits are particularly appealing to aging populations, who are more susceptible to these conditions. As a result, Vitamin K2 supplements have become a popular choice among older adults looking to enhance their health and quality of life.
“Powder & Crystalline form is the dominant market in the vitamin K2 market.”
The powder & crystalline form of Vitamin K2 is emerging as the dominant segment in the Vitamin K2 market, driven by its versatile applications and numerous advantages over other forms. This trend reflects a growing preference for powdered supplements in both the consumer and industrial markets, underscoring the convenience, stability, and efficacy that powdered Vitamin K2 offers.
The factor contributing to the dominance of the powder form in the Vitamin K2 market is its exceptional versatility. Vitamin K2 powder can be easily incorporated into a wide range of products, including dietary supplements, functional foods, and beverages. This adaptability allows manufacturers to create a diverse array of Vitamin K2-enriched products, catering to various consumer preferences and dietary needs. For example, powdered Vitamin K2 can be seamlessly blended into protein shakes, nutritional bars, dairy products, and even baked goods, making it a suitable choice for both health enthusiasts and the general population.
The break-up of the profile of primary participants in the vitamin K2 market:
• By Company Type: Tier 1 – 35%, Tier 2 – 30%, and Tier 3 – 35%
• By Designation: C Level – 22%, Director Level – 33%, Others – 45%
• By Region: North America – 17%, Europe – 26%, Asia Pacific – 38%, and Rest of the World – 19%
Prominent companies include Gnosis by Lesaffre (NattoPharma) (France), Kappa Bioscience AS (Balchem Corp.) (US), J-OIL MILLS INC. (Japan), Novozymes A/S (Denmark), BASF SE (Germany), Sungen Bioscience Co.,Ltd. (China), Vesta Nutra (US), Richen Nutritional Technology Co., Ltd. (China), Menadiona (Spain), and GENOFOCUS (Korea) among others.
Research Coverage:
This research report categorizes the vitamin K2 market by Product Type (MK-4, MK-7), Source (Natural, Synthetic), Form (Capsules & Tablets, Powder & Crystalline, Oils & Liquid), Application (Pharmaceuticals, Functional Food & Beverages, Health Supplements), and Region (North America, Europe, Asia Pacific, and Rest of the World).
The report covers information about the key factors, such as drivers, restraints, opportunities, and challenges impacting the growth of the vitamin K2 market. It also provides a detailed analysis of the major players in the market, including their business overview, products offered, key strategies, partnerships, new product launches, expansions, and acquisitions. Competitive benchmarking of upcoming startups in the vitamin K2 market is covered in this report.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall vitamin K2 market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
• Analysis of key drivers (Growth in health consciousness among consumers and increasing health expenditure, and Increase in research and application of vitamin K2), restraints (Inconsistency in regulatory norms governing vitamin K2, and Price volatility of raw materials), opportunities (Growing demand for natural and functional foods, Demand for personalized nutrition and tailored menaquinone products, and Untapped vitamin K2 applications), and challenges (Lack of consumer awareness regarding benefits specific to vitamin K2, and High research and development costs) influencing the growth of the vitamin K2 market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the vitamin K2 market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the vitamin K2 market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the vitamin K2 market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Gnosis by Lesaffre (NattoPharma) (France), Kappa Bioscience AS (Balchem Corp.) (US), J-OIL MILLS INC. (Japan), Novozymes A/S (Denmark), BASF SE (Germany), Sungen Bioscience Co.,Ltd. (China), Vesta Nutra (US), Richen Nutritional Technology Co., Ltd. (China), Menadiona (Spain), and GENOFOCUS (Korea), among others in the vitamin K2 market strategies. The report also helps stakeholders understand the vitamin K2 market and provides them with information on key market drivers, restraints, challenges, and opportunities.
Table of Contents
1 INTRODUCTION 31
1.1 STUDY OBJECTIVES 31
1.2 MARKET DEFINITION 31
1.2.1 INCLUSIONS AND EXCLUSIONS 32
TABLE 1 INCLUSIONS AND EXCLUSIONS 32
1.3 STUDY SCOPE 33
1.3.1 MARKET SEGMENTATION 33
1.3.2 REGIONS COVERED 33
1.3.3 YEARS CONSIDERED 34
1.4 UNIT CONSIDERED 34
1.4.1 CURRENCY UNIT 34
TABLE 2 USD EXCHANGE RATES, 2020–2023 35
1.4.2 VOLUME UNIT 35
1.5 STAKEHOLDERS 35
1.6 RECESSION IMPACT 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DATA 36
FIGURE 1 VITAMIN K2 MARKET: RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 37
2.1.2.1 Key data from primary sources 37
2.1.2.2 Key insights from industry experts 38
2.1.2.3 Breakdown of primaries 39
2.2 MARKET SIZE ESTIMATION 39
2.2.1 TOP-DOWN APPROACH 40
FIGURE 2 VITAMIN K2 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 40
2.2.2 SUPPLY-SIDE ANALYSIS 40
FIGURE 3 VITAMIN K2 MARKET SIZE CALCULATION: SUPPLY-SIDE ANALYSIS 41
2.2.3 BOTTOM-UP APPROACH 41
FIGURE 4 VITAMIN K2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 42
2.3 DATA TRIANGULATION 43
FIGURE 5 DATA TRIANGULATION 43
2.4 RESEARCH ASSUMPTIONS 44
2.5 LIMITATIONS AND RISK ASSESSMENT 45
2.6 RECESSION IMPACT ANALYSIS 45
2.6.1 RECESSION MACROINDICATORS 45
FIGURE 6 INDICATORS OF RECESSION 45
FIGURE 7 GLOBAL INFLATION RATE, 2012–2022 46
FIGURE 8 GLOBAL GROSS DOMESTIC PRODUCT, 2012–2022 (USD TRILLION) 47
FIGURE 9 RECESSION INDICATORS AND THEIR IMPACT ON VITAMIN K2 MARKET 48
FIGURE 10 GLOBAL VITAMIN K2 MARKET: CURRENT FORECAST VS. RECESSION FORECAST 48
3 EXECUTIVE SUMMARY 50
TABLE 3 VITAMIN K2 MARKET SNAPSHOT, 2024 VS. 2029 50
FIGURE 11 MK-7 SEGMENT TO HOLD LARGER MARKET SIZE IN 2024 51
FIGURE 12 POWDER AND CRYSTALLINE TO BE LARGEST APPLICATION FORM SEGMENT IN 2024 52
FIGURE 13 NATURAL SOURCE SEGMENT TO DOMINATE MARKET IN 2024 52
FIGURE 14 PHARMACEUTICALS APPLICATION SEGMENT TO EXHIBIT HIGHEST CAGR DURING FORECAST PERIOD 53
FIGURE 15 ASIA PACIFIC HELD LARGEST MARKET SHARE IN 2023 54
4 PREMIUM INSIGHTS 55
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN VITAMIN K2 MARKET 55
FIGURE 16 GROWING CONSUMER PREFERENCES FOR NATURAL AND ORGANIC PRODUCTS TO DRIVE DEMAND FOR VITAMIN K2 55
4.2 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE AND KEY COUNTRY 55
FIGURE 17 MK-7 SEGMENT AND CHINA TO ACCOUNT FOR SIGNIFICANT MARKET SHARES IN 2024 55
4.3 VITAMIN K2 MARKET: SHARE OF MAJOR REGIONAL SUBMARKETS 56
FIGURE 18 US ACCOUNTED FOR LARGEST SHARE IN 2023 56
4.4 VITAMIN K2 MARKET, BY PRODUCT TYPE AND REGION 57
FIGURE 19 MK-7 SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 57
4.5 VITAMIN K2 MARKET, BY APPLICATION FORM 57
FIGURE 20 POWDER AND CRYSTALLINE SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 57
4.6 VITAMIN K2 MARKET, BY SOURCE 58
FIGURE 21 NATURAL SEGMENT TO ACCOUNT FOR LARGER MARKET SIZE DURING FORECAST PERIOD 58
4.7 VITAMIN K2 MARKET, BY APPLICATION 58
FIGURE 22 HEALTH SUPPLEMENTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 58
5 MARKET OVERVIEW 59
5.1 INTRODUCTION 59
5.2 MACROECONOMIC INDICATORS 59
5.2.1 RISING GDP AND POPULATION 59
FIGURE 23 GLOBAL POPULATION GROWTH, 1950–2050 (BILLION) 60
FIGURE 24 GDP GROWTH, 2016–2023 (USD TRILLION) 60
5.2.2 RISE IN HEALTH CONCERNS AND DISEASE INCIDENCES 60
FIGURE 25 GLOBAL TRENDS IN DEATHS DUE TO CVD, 1990-2030 61
5.2.3 INCREASE IN CONSUMPTION OF DIETARY FIBERS 61
5.3 MARKET DYNAMICS 62
FIGURE 26 VITAMIN K2 MARKET: MARKET DYNAMICS 62
5.3.1 DRIVERS 62
5.3.1.1 Rising health consciousness among consumers 62
FIGURE 27 OECD HEALTH SPENDING AS SHARE OF GDP, 2017–2021 63
5.3.1.2 Growing research and development activities 63
FIGURE 28 GLOBAL EXPANSION OF VITAMIN K2 RESEARCH OVER THREE DECADES (1990-2020) 64
5.3.2 RESTRAINTS 65
5.3.2.1 Inconsistency in regulatory norms 65
5.3.2.2 Price volatility of raw materials 65
5.3.3 OPPORTUNITIES 66
5.3.3.1 Growing demand for natural and plant-based ingredients 66
5.3.3.2 Rising need for personalized nutrition and customized products 66
5.3.3.3 Untapped applications 67
5.3.4 CHALLENGES 67
5.3.4.1 Lack of consumer awareness regarding specific health benefits 67
5.3.4.2 High research and development costs 68
6 INDUSTRY TRENDS 69
6.1 INTRODUCTION 69
6.2 SUPPLY CHAIN ANALYSIS 69
FIGURE 29 VITAMIN K2 MARKET: SUPPLY CHAIN ANALYSIS 70
6.3 VALUE CHAIN ANALYSIS 71
FIGURE 30 VALUE CHAIN ANALYSIS: VITAMIN K2 MARKET 71
6.3.1 RAW MATERIAL SOURCING 72
6.3.2 MANUFACTURING AND PROCESSING 72
6.3.2.1 Product formulation and development 72
6.3.3 QUALITY ASSURANCE AND CERTIFICATION 72
6.3.4 MARKETING AND DISTRIBUTION 72
6.4 TRADE ANALYSIS 73
6.4.1 EXPORT SCENARIO 73
FIGURE 31 EXPORT VALUE OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629) FOR KEY COUNTRIES, 2019–2023 (USD THOUSAND) 73
6.4.2 IMPORT SCENARIO 73
FIGURE 32 IMPORT VALUE OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629) FOR KEY COUNTRIES, 2019–2023 (USD THOUSAND) 73
TABLE 4 TOP 10 EXPORTERS OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629), 2019–2023 (USD THOUSAND) 74
TABLE 5 TOP 10 EXPORTERS OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629), 2019–2023 (TON) 74
TABLE 6 TOP 10 IMPORTERS OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629), 2019–2023 (USD THOUSAND) 75
TABLE 7 TOP 10 IMPORTERS OF VITAMINS AND THEIR DERIVATIVES (HS CODE 293629), 2019–2023 (TON) 75
6.5 TECHNOLOGY ANALYSIS 76
6.5.1 KEY TECHNOLOGY 76
6.5.1.1 Fermentation technology 76
6.5.2 COMPLEMENTARY TECHNOLOGY 76
6.5.2.1 Encapsulation technology 76
6.5.3 ADJACENT TECHNOLOGY 76
6.5.3.1 Biotechnology 76
6.6 PRICING ANALYSIS 76
6.6.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT TYPE 77
TABLE 8 AVERAGE SELLING PRICE (ASP), BY PRODUCT TYPE, 2020–2023 (USD/TON) 77
FIGURE 33 AVERAGE SELLING PRICE TREND, BY PRODUCT TYPE, 2020–2023 (USD/TON) 77
6.6.2 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION 77
TABLE 9 AVERAGE SELLING PRICE (ASP), BY REGION, 2020–2023 (USD/TON) 78
6.7 ECOSYSTEM ANALYSIS 78
6.7.1 DEMAND SIDE 78
6.7.2 SUPPLY SIDE 78
FIGURE 34 KEY PLAYERS IN VITAMIN K2 ECOSYSTEM 79
TABLE 10 VITAMIN K2 MARKET ECOSYSTEM 79
6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 80
FIGURE 35 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 80
6.9 PATENT ANALYSIS 81
FIGURE 36 NUMBER OF PATENTS GRANTED FOR VITAMIN K2 MARKET, 2013–2023 81
FIGURE 37 REGIONAL ANALYSIS OF PATENTS GRANTED FOR VITAMIN K2 MARKET, 2013–2023 81
6.9.1 LIST OF MAJOR PATENTS 82
TABLE 11 LIST OF MAJOR PATENTS PERTAINING TO VITAMIN K2, 2020–2023 82
6.10 KEY CONFERENCES AND EVENTS, 2024–2025 85
TABLE 12 VITAMIN K2 MARKET: KEY DETAILED LIST OF CONFERENCES AND EVENTS, 2024–2025 85
6.11 REGULATORY LANDSCAPE 86
6.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86
TABLE 13 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86
TABLE 14 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87
TABLE 15 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88
6.11.1.1 Regulations in North America 88
6.11.1.1.1 US 88
6.11.1.1.2 Canada 88
6.11.1.2 Regulations in Europe 89
6.11.1.3 Regulations in Asia Pacific 89
6.11.1.3.1 China 89
6.11.1.3.2 India 89
6.12 PORTER’S FIVE FORCES ANALYSIS 89
TABLE 16 IMPACT OF PORTER’S FIVE FORCES ON VITAMIN K2 MARKET 89
FIGURE 38 PORTER’S FIVE FORCES ANALYSIS: VITAMIN K2 MARKET 90
6.12.1 INTENSITY OF COMPETITIVE RIVALRY 90
6.12.2 BARGAINING POWER OF SUPPLIERS 90
6.12.3 BARGAINING POWER OF BUYERS 91
6.12.4 THREAT OF NEW ENTRANTS 91
6.12.5 THREAT OF SUBSTITUTES 91
6.13 KEY STAKEHOLDERS AND BUYING CRITERIA 91
6.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 91
FIGURE 39 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VITAMIN K2 PRODUCT TYPES 92
TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VITAMIN K2 PRODUCT TYPES 92
6.13.2 BUYING CRITERIA 92
FIGURE 40 KEY BUYING CRITERIA FOR VITAMIN K2 PRODUCT TYPES 93
TABLE 18 KEY BUYING CRITERIA FOR VITAMIN K2 PRODUCT TYPES 93
6.14 CASE STUDY ANALYSIS 94
6.14.1 ESTABLISHING DISTINCT RECOMMENDED DIETARY INTAKE TO PROMOTE HEALTHIER DIETARY CHOICES 94
6.14.2 ENHANCING ABILITY IN NUTRACEUTICAL FORMULATIONS FOR IMPROVED QUALITY AND EFFICACY 94
6.15 INVESTMENT AND FUNDING SCENARIO 95
FIGURE 41 INVESTMENT AND FUNDING SCENARIO, 2019–2024 (USD MILLION) 95
7 VITAMIN K2 MARKET, BY FUNCTION 96
7.1 INTRODUCTION 96
7.2 BONE AND CARDIOVASCULAR HEALTH 97
7.2.1 COMPREHENSIVE HEALTH BENEFITS TO DRIVE MARKET 97
7.3 BLOOD HEALTH AND CLOTTING 97
7.3.1 EFFICACY IN MANAGING CLOTTING DISORDERS TO BOOST MARKET GROWTH 97
7.4 ANTI-INFLAMMATORY AND IMMUNITY 98
7.4.1 THERAPEUTIC POTENTIAL AND IMMUNITY-SUPPORTING PROPERTIES TO SUPPORT MARKET GROWTH 98
7.5 OTHER FUNCTIONS 98
8 VITAMIN K2 MARKET, BY PRODUCT TYPE 100
8.1 INTRODUCTION 101
TABLE 19 PRODUCT TYPE: OVERVIEW 101
FIGURE 42 MK-7 SEGMENT TO ACCOUNT FOR LARGEST MARKET SIZE DURING FORECAST PERIOD 102
TABLE 20 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 102
TABLE 21 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 102
TABLE 22 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (TON) 102
TABLE 23 VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (TON) 103
8.2 MK-4 103
8.2.1 POTENTIAL BENEFITS IN BONE AND CARDIOVASCULAR HEALTH TO DRIVE MARKET GROWTH 103
TABLE 24 MK-4: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION) 104
TABLE 25 MK-4: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION) 104
TABLE 26 MK-4: VITAMIN K2 MARKET, BY REGION, 2020–2023 (TON) 104
TABLE 27 MK-4: VITAMIN K2 MARKET, BY REGION, 2024–2029 (TON) 104
8.3 MK-7 105
8.3.1 HIGH BIOAVAILABILITY TO PROPEL MARKET GROWTH 105
TABLE 28 MK-7: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION) 105
TABLE 29 MK-7: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION) 106
TABLE 30 MK-7: VITAMIN K2 MARKET, BY REGION, 2020–2023 (TON) 106
TABLE 31 MK-7: VITAMIN K2 MARKET, BY REGION, 2024–2029 (TON) 106
9 VITAMIN K2 MARKET, BY APPLICATION FORM 107
9.1 INTRODUCTION 108
FIGURE 43 POWDER AND CRYSTALLINE SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 108
TABLE 32 VITAMIN K2 MARKET, BY APPLICATION FORM, 2020–2023 (USD MILLION) 108
TABLE 33 VITAMIN K2 MARKET, BY APPLICATION FORM, 2024–2029 (USD MILLION) 109
9.2 CAPSULES AND TABLETS 109
9.2.1 ABILITY TO CATER TO DIVERSE CONSUMER NEEDS AND PREFERENCES TO DRIVE MARKET 109
TABLE 34 CAPSULES AND TABLETS: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION) 109
TABLE 35 CAPSULES AND TABLETS: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION) 109
9.3 POWDER AND CRYSTALLINE 110
9.3.1 SURGING DEMAND FOR CUSTOMIZABLE DOSAGES AND HIGH PURITY TO PROPEL MARKET GROWTH 110
TABLE 36 POWDER AND CRYSTALLINE: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION) 110
TABLE 37 POWDER AND CRYSTALLINE: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION) 110
9.4 LIQUIDS 111
9.4.1 GROWING NEED FOR SUPPLEMENTS WITH ENHANCED BIOAVAILABILITY TO BOOST SEGMENT GROWTH 111
TABLE 38 LIQUIDS: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION) 111
TABLE 39 LIQUIDS: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION) 111
10 VITAMIN K2 MARKET, BY SOURCE 112
10.1 INTRODUCTION 113
FIGURE 44 NATURAL SEGMENT TO ACCOUNT FOR LARGEST MARKET SIZE DURING FORECAST PERIOD 113
TABLE 40 VITAMIN K2 MARKET: BY SOURCE, 2020–2023 (USD MILLION) 114
TABLE 41 VITAMIN K2 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 114
10.2 NATURAL 114
10.2.1 INCREASING CONSUMER PREFERENCE FOR NON-GMO SUPPLEMENTS TO BOOST MARKET GROWTH 114
TABLE 42 NATURAL: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION) 114
TABLE 43 NATURAL: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION) 115
10.3 SYNTHETIC 115
10.3.1 LOW PRODUCTION COST TO DRIVE MARKET 115
TABLE 44 SYNTHETIC: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION) 115
TABLE 45 SYNTHETIC: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION) 115
11 VITAMIN K2 MARKET, BY APPLICATION 116
11.1 INTRODUCTION 117
TABLE 46 APPLICATION: OVERVIEW 117
FIGURE 45 HEALTH SUPPLEMENTS SEGMENT TO ACCOUNT FOR LARGEST MARKET SIZE DURING FORECAST PERIOD 118
TABLE 47 VITAMIN K2 MARKET: BY APPLICATION, 2020–2023 (USD MILLION) 118
TABLE 48 VITAMIN K2 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 118
11.2 PHARMACEUTICALS 119
11.2.1 RISING GOVERNMENT INVESTMENTS IN DEVELOPMENT OF NEW FORMULATIONS TO DRIVE MARKET 119
TABLE 49 PHARMACEUTICALS: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION) 119
TABLE 50 PHARMACEUTICALS: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION) 120
11.3 FUNCTIONAL FOODS AND BEVERAGES 120
11.3.1 GROWING DEMAND FOR FORTIFIED FUNCTIONAL FOODS TO PROPEL MARKET GROWTH 120
TABLE 51 FUNCTIONAL FOODS AND BEVERAGES: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION) 120
TABLE 52 FUNCTIONAL FOODS AND BEVERAGES: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION) 121
11.4 HEALTH SUPPLEMENTS 121
11.4.1 INCREASED AWARENESS REGARDING ASSOCIATED HEALTH BENEFITS TO DRIVE MARKET 121
TABLE 53 HEALTH SUPPLEMENTS: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION) 122
TABLE 54 HEALTH SUPPLEMENTS: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION) 122
12 VITAMIN K2 MARKET, BY REGION 123
12.1 INTRODUCTION 124
FIGURE 46 ITALY TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 124
TABLE 55 VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION) 125
TABLE 56 VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION) 125
TABLE 57 VITAMIN K2 MARKET, BY REGION, 2020–2023 (TON) 125
TABLE 58 VITAMIN K2 MARKET, BY REGION, 2024–2029 (TON) 125
12.2 NORTH AMERICA 126
TABLE 59 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2020–2023 (USD MILLION) 126
TABLE 60 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 126
TABLE 61 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2020–2023 (TON) 126
TABLE 62 NORTH AMERICA: VITAMIN K2 MARKET, BY COUNTRY, 2024–2029 (TON) 127
TABLE 63 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 127
TABLE 64 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 127
TABLE 65 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (TON) 127
TABLE 66 NORTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (TON) 128
TABLE 67 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION FORM, 2020–2023 (USD MILLION) 128
TABLE 68 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION FORM, 2024–2029 (USD MILLION) 128
TABLE 69 NORTH AMERICA: VITAMIN K2 MARKET, BY SOURCE, 2020–2023 (USD MILLION) 128
TABLE 70 NORTH AMERICA: VITAMIN K2 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 129
TABLE 71 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 129
TABLE 72 NORTH AMERICA: VITAMIN K2 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 129
12.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS 129
FIGURE 47 INFLATION IN NORTH AMERICA: COUNTRY-LEVEL DATA, 2017–2022 130
FIGURE 48 NORTH AMERICA: VITAMIN K2 MARKET, RECESSION IMPACT ANALYSIS 130
12.2.2 US 130
12.2.2.1 Growing awareness regarding importance of preventive health measures to drive market 130
TABLE 73 US: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 131
TABLE 74 US: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 131
12.2.3 CANADA 131
12.2.3.1 Increasing focus on preventive healthcare and natural products to propel market 131
TABLE 75 CANADA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 132
TABLE 76 CANADA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 132
12.2.4 MEXICO 132
12.2.4.1 High prevalence of chronic lifestyle diseases to drive market 132
TABLE 77 MEXICO: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 132
TABLE 78 MEXICO: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 133
12.3 EUROPE 133
FIGURE 49 EUROPE: VITAMIN K2 MARKET SNAPSHOT 134
TABLE 79 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2020–2023 (USD MILLION) 134
TABLE 80 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 135
TABLE 81 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2020–2023 (TON) 135
TABLE 82 EUROPE: VITAMIN K2 MARKET, BY COUNTRY, 2024–2029 (TON) 135
TABLE 83 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 136
TABLE 84 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 136
TABLE 85 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (TON) 136
TABLE 86 EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (TON) 136
TABLE 87 EUROPE: VITAMIN K2 MARKET, BY APPLICATION FORM, 2020–2023 (USD MILLION) 136
TABLE 88 EUROPE: VITAMIN K2 MARKET, BY APPLICATION FORM, 2024–2029 (USD MILLION) 137
TABLE 89 EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2020–2023 (USD MILLION) 137
TABLE 90 EUROPE: VITAMIN K2 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 137
TABLE 91 EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 137
TABLE 92 EUROPE: VITAMIN K2 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 138
12.3.1 EUROPE: RECESSION IMPACT ANALYSIS 138
FIGURE 50 INFLATION IN EUROPE: COUNTRY-LEVEL DATA, 2017-2022 138
FIGURE 51 EUROPE: VITAMIN K2 MARKET, RECESSION IMPACT ANALYSIS 139
12.3.2 GERMANY 139
12.3.2.1 Rising focus on proactive healthcare to drive market 139
TABLE 93 GERMANY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 139
TABLE 94 GERMANY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 139
12.3.3 FRANCE 140
12.3.3.1 Innovative products and investments in research and development to boost market growth 140
TABLE 95 FRANCE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 140
TABLE 96 FRANCE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 140
12.3.4 UK 140
12.3.4.1 Rapidly aging population to propel market growth 140
TABLE 97 UK: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 141
TABLE 98 UK: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 141
12.3.5 ITALY 141
12.3.5.1 Evolving dietary preferences to boost market growth 141
TABLE 99 ITALY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 142
TABLE 100 ITALY: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 142
12.3.6 SPAIN 142
12.3.6.1 Growing consumer interest in health supplements to propel drive demand 142
TABLE 101 SPAIN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 142
TABLE 102 SPAIN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 143
12.3.7 REST OF EUROPE 143
TABLE 103 REST OF EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 143
TABLE 104 REST OF EUROPE: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 143
12.4 ASIA PACIFIC 144
FIGURE 52 ASIA PACIFIC VITAMIN K2 MARKET SNAPSHOT 144
TABLE 105 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2020–2023 (USD MILLION) 145
TABLE 106 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 145
TABLE 107 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2020–2023 (TON) 145
TABLE 108 ASIA PACIFIC: VITAMIN K2 MARKET, BY COUNTRY, 2024–2029 (TON) 146
TABLE 109 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 146
TABLE 110 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 146
TABLE 111 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (TON) 146
TABLE 112 ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (TON) 147
TABLE 113 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION FORM, 2020–2023 (USD MILLION) 147
TABLE 114 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION FORM, 2024–2029 (USD MILLION) 147
TABLE 115 ASIA PACIFIC: VITAMIN K2 MARKET, BY SOURCE, 2020–2023 (USD MILLION) 147
TABLE 116 ASIA PACIFIC: VITAMIN K2 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 147
TABLE 117 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 148
TABLE 118 ASIA PACIFIC: VITAMIN K2 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 148
12.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS 148
FIGURE 53 INFLATION IN ASIA PACIFIC: COUNTRY-LEVEL DATA, 2017-2022 149
FIGURE 54 ASIA PACIFIC: VITAMIN K2 MARKET, RECESSION IMPACT ANALYSIS 149
12.4.2 CHINA 149
12.4.2.1 Surging use of digital media to disseminate healthcare information to propel market 149
TABLE 119 CHINA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 150
TABLE 120 CHINA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 150
12.4.3 JAPAN 150
12.4.3.1 Consumer preferences for natural healthcare solutions to boost market growth 150
TABLE 121 JAPAN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 151
TABLE 122 JAPAN: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 151
12.4.4 INDIA 151
12.4.4.1 Strategic market penetration initiatives by various companies to drive market 151
TABLE 123 INDIA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 152
TABLE 124 INDIA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 152
12.4.5 AUSTRALIA AND NEW ZEALAND 152
12.4.5.1 Changing consumer preferences and increasing health consciousness to drive demand 152
TABLE 125 AUSTRALIA AND NEW ZEALAND: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 153
TABLE 126 AUSTRALIA AND NEW ZEALAND: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 153
12.4.6 REST OF ASIA PACIFIC 153
TABLE 127 REST OF ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 154
TABLE 128 REST OF ASIA PACIFIC: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 154
12.5 ROW 154
TABLE 129 ROW: VITAMIN K2 MARKET, BY REGION, 2020–2023 (USD MILLION) 154
TABLE 130 ROW: VITAMIN K2 MARKET, BY REGION, 2024–2029 (USD MILLION) 155
TABLE 131 ROW: VITAMIN K2 MARKET, BY REGION, 2020–2023 (TON) 155
TABLE 132 ROW: VITAMIN K2 MARKET, BY REGION, 2024–2029 (TON) 155
TABLE 133 ROW: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 155
TABLE 134 ROW: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 155
TABLE 135 ROW: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (TON) 156
TABLE 136 ROW: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (TON) 156
TABLE 137 ROW: VITAMIN K2 MARKET, BY APPLICATION FORM, 2020–2023 (USD MILLION) 156
TABLE 138 ROW: VITAMIN K2 MARKET, BY APPLICATION FORM, 2024–2029 (USD MILLION) 156
TABLE 139 ROW: VITAMIN K2 MARKET, BY SOURCE, 2020–2023 (USD MILLION) 157
TABLE 140 ROW: VITAMIN K2 MARKET, BY SOURCE, 2024–2029 (USD MILLION) 157
TABLE 141 ROW: VITAMIN K2 MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 157
TABLE 142 ROW: VITAMIN K2 MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 157
12.5.1 ROW: RECESSION IMPACT ANALYSIS 157
FIGURE 55 INFLATION IN ROW, COUNTRY-LEVEL DATA, 2017-2022 158
FIGURE 56 ROW: VITAMIN K2 MARKET, RECESSION IMPACT ANALYSIS 158
12.5.2 SOUTH AMERICA 159
12.5.2.1 Collaboration among key market players to drive market growth 159
TABLE 143 SOUTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 159
TABLE 144 SOUTH AMERICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 159
12.5.3 MIDDLE EAST AND AFRICA 160
12.5.3.1 Developing regulatory landscape to propel market growth 160
TABLE 145 MIDDLE EAST AND AFRICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION) 160
TABLE 146 MIDDLE EAST AND AFRICA: VITAMIN K2 MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION) 160
13 COMPETITIVE LANDSCAPE 161
13.1 OVERVIEW 161
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 161
TABLE 147 OVERVIEW OF STRATEGIES ADOPTED BY KEY VITAMIN K2 VENDORS 161
13.3 REVENUE ANALYSIS 163
FIGURE 57 REVENUE ANALYSIS FOR KEY COMPANIES IN LAST THREE YEARS, 2021–2023 (USD MILLION) 163
13.4 MARKET SHARE ANALYSIS 164
FIGURE 58 SHARE OF LEADING COMPANIES IN VITAMIN K2 MARKET, 2023 164
TABLE 148 VITAMIN K2 MARKET: DEGREE OF COMPETITION 165
13.5 COMPANY VALUATION AND FINANCIAL METRICS 166
13.5.1 COMPANY VALUATION 166
FIGURE 59 COMPANY VALUATION OF KEY VITAMIN K2 VENDORS, 2023 (USD BILLION) 166
13.5.2 EV/EBITDA 166
FIGURE 60 EV/EBITDA OF KEY COMPANIES, 2023 166
13.6 BRAND/PRODUCT COMPARISON ANALYSIS 167
FIGURE 61 BRAND/PRODUCT COMPARISON ANALYSIS, BY PRODUCT TYPE 167
13.6.1 MENAQUINGOLD 167
13.6.2 MENAQ7 168
13.6.3 K2VITAL 168
13.6.4 VITAMK7 168
13.6.5 MENATTO 168
13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 169
13.7.1 STARS 169
13.7.2 EMERGING LEADERS 169
13.7.3 PERVASIVE PLAYERS 169
13.7.4 PARTICIPANTS 170
FIGURE 62 VITAMIN K2 MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 170
13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 171
13.7.5.1 Company footprint 171
FIGURE 63 VITAMIN K2 MARKET: COMPANY FOOTPRINT 171
13.7.5.2 Regional footprint 171
TABLE 149 VITAMIN K2 MARKET: REGIONAL FOOTPRINT 171
13.7.5.3 Product type footprint 172
TABLE 150 VITAMIN K2 MARKET: PRODUCT TYPE FOOTPRINT 172
13.7.5.4 Application footprint 173
TABLE 151 VITAMIN K2 MARKET: APPLICATION FOOTPRINT 173
13.7.5.5 Source footprint 173
TABLE 152 VITAMIN K2 MARKET: SOURCE FOOTPRINT 173
13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 174
13.8.1 PROGRESSIVE COMPANIES 174
13.8.2 RESPONSIVE COMPANIES 174
13.8.3 DYNAMIC COMPANIES 174
13.8.4 STARTING BLOCKS 174
FIGURE 64 VITAMIN K2 MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 175
13.8.5 COMPETITIVE BENCHMARKING 175
13.8.5.1 Detailed list of key startups/SMEs 175
TABLE 153 VITAMIN K2 MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2023 175
13.8.5.2 Competitive benchmarking of key startup/SMEs 176
TABLE 154 VITAMIN K2 MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SMES 176
13.9 COMPETITIVE SCENARIO AND TRENDS 176
13.9.1 PRODUCT LAUNCHES AND DEVELOPMENTS 176
TABLE 155 VITAMIN K2 MARKET: PRODUCT LAUNCHES AND DEVELOPMENTS, JANUARY 2020–JUNE 2024 177
13.9.2 DEALS 178
TABLE 156 VITAMIN K2 MARKET: DEALS, JANUARY 2020–JUNE 2024 178
13.9.3 EXPANSIONS 180
TABLE 157 VITAMIN K2 MARKET: EXPANSIONS, JANUARY 2020–JUNE 2024 180
13.9.4 OTHERS 181
TABLE 158 VITAMIN K2 MARKET: OTHER DEVELOPMENTS, JANUARY 2020 – JUNE 2024 181
14 COMPANY PROFILES 182
14.1 KEY PLAYERS 182
(Business overview, Products/Solutions/Services offered, Recent developments, MnM view, Right to win, Strategic choices, and Weaknesses and Competitive threats)*
14.1.1 GNOSIS BY LESAFFRE (NATTOPHARMA) 182
TABLE 159 GNOSIS BY LESAFFRE (NATTOPHARMA): COMPANY OVERVIEW 183
TABLE 160 GNOSIS BY LESAFFRE (NATTOPHARMA): PRODUCTS/SOLUTIONS/SERVICES OFFERED 183
TABLE 161 GNOSIS BY LESAFFRE (NATTOPHARMA): PRODUCT LAUNCHES AND DEVELOPMENTS 183
TABLE 162 GNOSIS BY LESAFFRE (NATTOPHARMA): DEALS 184
TABLE 163 GNOSIS BY LESAFFRE (NATTOPHARMA): OTHER DEALS/DEVELOPMENTS 185
14.1.2 KAPPA BIOSCIENCE AS (BALCHEM CORP.) 186
TABLE 164 KAPPA BIOSCIENCE AS (BALCHEM CORP.): COMPANY OVERVIEW 186
FIGURE 65 KAPPA BIOSCIENCE AS (BALCHEM CORP.): COMPANY SNAPSHOT 187
TABLE 165 KAPPA BIOSCIENCE AS (BALCHEM CORP.): PRODUCTS/SOLUTIONS/SERVICES OFFERED 187
TABLE 166 KAPPA BIOSCIENCE AS (BALCHEM CORP.): PRODUCT LAUNCHES AND DEVELOPMENTS 188
TABLE 167 KAPPA BIOSCIENCE AS (BALCHEM CORP.): DEALS 188
TABLE 168 KAPPA BIOSCIENCE AS (BALCHEM CORP.): EXPANSIONS 189
TABLE 169 KAPPA BIOSCIENCE AS (BALCHEM CORP.): OTHER DEALS/DEVELOPMENTS 189
14.1.3 J-OIL MILLS, INC. 191
TABLE 170 J-OIL MILLS, INC.: COMPANY OVERVIEW 191
FIGURE 66 J-OIL MILLS, INC.: COMPANY SNAPSHOT 191
TABLE 171 J-OIL MILLS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 192
TABLE 172 J-OIL MILLS, INC.: PRODUCT LAUNCHES AND DEVELOPMENTS 192
TABLE 173 J-OIL MILLS, INC.: DEALS 192
14.1.4 NOVOZYMES A/S 194
TABLE 174 NOVOZYMES A/S: COMPANY OVERVIEW 194
FIGURE 67 NOVOZYMES A/S: COMPANY SNAPSHOT 195
TABLE 175 NOVOZYMES A/S: PRODUCTS/SOLUTIONS/SERVICES OFFERED 195
TABLE 176 NOVOZYMES A/S: DEALS 196
14.1.5 BASF SE 197
TABLE 177 BASF SE: COMPANY OVERVIEW 197
FIGURE 68 BASF SE: COMPANY SNAPSHOT 198
TABLE 178 BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 198
14.1.6 SUNGEN BIOSCIENCE CO.,LTD 200
TABLE 179 SUNGEN BIOSCIENCE CO.,LTD: COMPANY OVERVIEW 200
TABLE 180 SUNGEN BIOSCIENCE CO.,LTD: PRODUCTS/SOLUTIONS/SERVICES OFFERED 200
14.1.7 VESTA NUTRA 202
TABLE 181 VESTA NUTRA: COMPANY OVERVIEW 202
TABLE 182 VESTA NUTRA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 202
14.1.8 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD. 203
TABLE 183 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 203
TABLE 184 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 203
TABLE 185 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.: OTHER DEVELOPMENTS 204
14.1.9 MENADIONA 205
TABLE 186 MENADIONA: COMPANY OVERVIEW 205
TABLE 187 MENADIONA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 205
TABLE 188 MENADIONA: PRODUCT LAUNCHES AND DEVELOPMENTS 206
14.1.10 GENOFOCUS 207
TABLE 189 GENOFOCUS: COMPANY OVERVIEW 207
TABLE 190 GENOFOCUS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 207
TABLE 191 GENOFOCUS: PRODUCT LAUNCHES AND DEVELOPMENTS 208
14.1.11 ANGELYEAST CO., LTD. 209
TABLE 192 ANGELYEAST CO., LTD.: COMPANY OVERVIEW 209
TABLE 193 ANGELYEAST CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 209
14.1.12 GENEFERM BIOTECHNOLOGY CO., LTD. 211
TABLE 194 GENEFERM BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW 211
TABLE 195 GENEFERM BIOTECHNOLOGY CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 211
14.1.13 NAKODA CHEMICALS LTD. 212
TABLE 196 NAKODA CHEMICALS LTD.: COMPANY OVERVIEW 212
TABLE 197 NAKODA CHEMICALS LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 212
14.1.14 HAIHANG INDUSTRY 213
TABLE 198 HAIHANG INDUSTRY: COMPANY OVERVIEW 213
TABLE 199 HAIHANG INDUSTRY: PRODUCTS/SOLUTIONS/SERVICES OFFERED 213
14.1.15 CHEMICEA LIMITED 214
TABLE 200 CHEMICEA LIMITED: COMPANY OVERVIEW 214
TABLE 201 CHEMICEA LIMITED: PRODUCTS/SOLUTIONS/SERVICES OFFERED 214
14.1.16 KYOWA HAKKO U.S.A., INC. 216
TABLE 202 KYOWA HAKKO U.S.A., INC.: BUSINESS OVERVIEW 216
TABLE 203 KYOWA HAKKO U.S.A., INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 216
14.2 STARTUPS/SMES 217
14.2.1 SEEBIO BIOTECH (SHANGHAI) CO.,LTD. 217
TABLE 204 SEEBIO BIOTECH (SHANGHAI) CO., LTD.: COMPANY OVERVIEW 217
14.2.2 MAGNESIA GMBH 218
TABLE 205 MAGNESIA GMBH: COMPANY OVERVIEW 218
14.2.3 FALCON TRADING INTERNATIONAL 219
TABLE 206 FALCON TRADING INTERNATIONAL: COMPANY OVERVIEW 219
14.2.4 ABCO INDIA 220
TABLE 207 ABCO INDIA: COMPANY OVERVIEW 220
14.2.5 ACT 221
TABLE 208 ACT: COMPANY OVERVIEW 221
*Details on Business overview, Products/Solutions/Services offered, Recent developments, MnM view, Right to win, Strategic choices, and Weaknesses and Competitive threats might not be captured in case of unlisted companies.
15 ADJACENT AND RELATED MARKETS 222
15.1 INTRODUCTION 222
TABLE 209 ADJACENT MARKETS TO VITAMIN K2 MARKET 222
15.2 LIMITATIONS 222
15.3 DIETARY SUPPLEMENTS MARKET 222
15.3.1 MARKET DEFINITION 222
15.3.2 MARKET OVERVIEW 223
TABLE 210 DIETARY SUPPLEMENTS MARKET, BY REGION, 2018–2022 (USD MILLION) 223
TABLE 211 DIETARY SUPPLEMENTS MARKET, BY REGION, 2023–2028 (USD MILLION) 223
15.4 VITAMINS MARKET 224
15.4.1 MARKET DEFINITION 224
15.4.2 MARKET OVERVIEW 224
TABLE 212 VITAMINS MARKET, BY REGION, 2017–2022 (USD MILLION) 224
TABLE 213 VITAMINS MARKET, BY REGION, 2023–2028 (USD MILLION) 225
16 APPENDIX 226
16.1 DISCUSSION GUIDE 226
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 231
16.3 CUSTOMIZATION OPTIONS 233
16.4 RELATED REPORTS 234
16.5 AUTHOR DETAILS 235
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11